PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc.

NASDAQ:PMCB

Overview | Financials
Company Name PharmaCyte Biotech, Inc.
Symbol PMCB
Currency USD
Price 1.9
Market Cap 14,647,974
Dividend Yield 0%
52-week-range 1.39 - 2.61
Industry Biotechnology
Sector Healthcare
CEO Mr. Joshua N. Silverman
Website https://pharmacyte.com

An error occurred while fetching data.

About PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced

Related Stocks

OKYO Pharma Limited logo

OKYO Pharma Limited

OKYO

1.03 USD

Aspira Women's Health Inc. logo

Aspira Women's Health Inc.

AWH

0.851 USD

BioSig Technologies, Inc. logo

BioSig Technologies, Inc.

BSGM

0.4 USD

Freeline Therapeutics Holdings plc logo

Freeline Therapeutics Holdings plc

FRLN

6.49 USD

Modular Medical, Inc. logo

Modular Medical, Inc.

MODD

2.33 USD

Financials

Numbers are in millions USD

Numbers are in millions USD